Form4insider filings, from the source

SEC Form 4 · accession 0001209191-19-003183

LA JOLLA PHARMACEUTICAL CO · LJPC

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Kevin C Tang
Director · 10% Owner
Period of report
Jan 7, 2019
Accepted (ET)
Jan 9, 2019 · 9:54 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 7, 2019P100,000$5.8384A3,738,893IBy LP
Common StockF3,F2Jan 8, 2019P200,000$5.332A3,938,893IBy LP
Common StockF4,F2Jan 8, 2019P200,000$5.2449A4,138,893IBy LP
Common StockF5,F2Jan 8, 2019P200,000$5.2397A4,338,893IBy LP
Common StockF6,F2Jan 8, 2019P200,000$5.3396A4,538,893IBy LP
Common StockF7,F2Jan 8, 2019P200,000$5.3785A4,738,893IBy LP
Common StockF8,F2Jan 8, 2019P120,786$5.4286A4,859,679IBy LP
Common StockF9,F2Jan 9, 2019P79,214$5.5395A4,938,893IBy LP

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses